Long Haulers should be noticeable group from our trials we have already. One would think that is possible to get an idea of percentage effected by checking our former trial patients. I remember hearing that all severe to critical patients treated in hospital fell into the Long Haulers group at high rate of 70-75% of the total treated. We could get a real good idea if our trials beat those high numbers just by contacting our trial patients. It would be nice information even though anecdotal.

Also, update us on the HIV population still taking weekly injections. Has anyone in that population come down with symptoms of Covid and tested positive? That would be nice to know too. Maybe send our HIV trial population a question flyer with their free Leronlimab for the ongoing trial participants to gather this anecdotal data.